| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARIAD PHARMACEUTICALS INC | 50,000 | 320,000 | 0.12% | Call | |
| 2 | ACCELERATE DIAGNOSTICS INC | 25,000 | 359,000 | 0.13% | Call | |
| 3 | DERMIRA INC | 20,000 | 414,000 | 0.15% | Put | |
| 4 | SANGAMO THERAPEUTICS INCORPORATED | 75,000 | 454,000 | 0.17% | ||
| 5 | SCYNEXIS INC | 125,000 | 504,000 | 0.18% | ||
| 6 | FORWARD PHARMA A/S | 30,000 | 510,000 | 0.19% | ||
| 7 | ENDOCHOICE HLDGS INC | 115,000 | 599,000 | 0.22% | ||
| 8 | EXELIXIS INC | 150,000 | 600,000 | 0.22% | ||
| 9 | PACIFIC BIOSCIENCES CALIF IN | 75,000 | 638,000 | 0.23% | ||
| 10 | ARIAD PHARMACEUTICALS ORD (NMS) | 100,000 | 639,000 | 0.23% | ||
| 11 | CARDIOVASCULAR SYS INC DEL COM | 75,000 | 778,000 | 0.29% | ||
| 12 | FLUIDIGM CORP DEL COM | 100,000 | 807,000 | 0.30% | ||
| 13 | IGNYTA INC COM | 125,000 | 846,000 | 0.31% | ||
| 14 | PUMA BIOTECHNOLOGY | 30,000 | 881,000 | 0.32% | ||
| 15 | AERIE PHARMACEUTICALS INC COM | 75,000 | 912,000 | 0.33% | ||
| 16 | Heartware International, Inc. | 30,000 | 943,000 | 0.35% | ||
| 17 | SAREPTA THERAPEUTICS INC | 50,000 | 976,000 | 0.36% | Call | |
| 18 | ONCOMED PHARMACEUTICALS INC | 100,000 | 1,011,000 | 0.37% | Call | |
| 19 | BLUEBIRD BIO INC COM | 25,000 | 1,063,000 | 0.39% | ||
| 20 | TRINET GROUP INC COM | 75,000 | 1,076,000 | 0.39% | ||
| 21 | ARATANA THERAPEUTICS INC | 200,000 | 1,104,000 | 0.40% | ||
| 22 | CYTOKINETICS INC | 175,000 | 1,234,000 | 0.45% | ||
| 23 | TANDEM DIABETES CARE INC COM | 150,000 | 1,307,000 | 0.48% | ||
| 24 | INTRA-CELLULAR THERAPIES INC | 50,000 | 1,390,000 | 0.51% | ||
| 25 | APPLIED GENETIC TECHNOL CORP | 100,000 | 1,398,000 | 0.51% | ||
| 26 | LDR HLDG CORP COM | 60,000 | 1,529,000 | 0.56% | ||
| 27 | DERMIRA INC COM | 75,000 | 1,551,000 | 0.57% | ||
| 28 | MAZOR ROBOTICS LTD | 125,000 | 1,555,000 | 0.57% | ||
| 29 | ALNYLAM PHARMACEUTICALS INC | 25,000 | 1,569,000 | 0.57% | Put | |
| 30 | SPECTRANETICS CORP | 110,000 | 1,597,000 | 0.59% | ||
| 31 | IMPAX LABORATORIES INC | 50,000 | 1,601,000 | 0.59% | ||
| 32 | MEDIVATION INC | 35,000 | 1,609,000 | 0.59% | Call | |
| 33 | ACCELERATE DIAGNOSTICS INC | 125,000 | 1,796,000 | 0.66% | ||
| 34 | GW PHARMACEUTICALS PLC | 25,000 | 1,804,000 | 0.66% | Call | |
| 35 | ACCELERON PHARMA INC | 75,000 | 1,979,000 | 0.73% | ||
| 36 | BROOKDALE SR LIVING INC | 125,000 | 1,985,000 | 0.73% | ||
| 37 | ADAPTIMMUNE THERAPEUTICS PLC | 250,000 | 2,033,000 | 0.74% | ||
| 38 | GLAUKOS CORP | 125,000 | 2,108,000 | 0.77% | ||
| 39 | COHERUS BIOSCIENCES INC COM | 100,000 | 2,123,000 | 0.78% | ||
| 40 | Hercules Offshore Inc | 225,000 | 2,270,000 | 0.83% | ||
| 41 | KITE PHARMA INCORPORATED | 50,000 | 2,296,000 | 0.84% | ||
| 42 | BIOMARIN PHARMACEUTICAL INC | 30,000 | 2,474,000 | 0.91% | ||
| 43 | MERCK & CO INC | 50,000 | 2,646,000 | 0.97% | Put | |
| 44 | DYNAVAX TECHNOLOGIES CORP | 140,000 | 2,694,000 | 0.99% | ||
| 45 | REGENERON PHARMACEUTICALS | 7,500 | 2,703,000 | 0.99% | ||
| 46 | REGENERON PHARMACEUTICALS | 7,500 | 2,703,000 | 0.99% | Put | |
| 47 | ADAMAS PHARMACEUTICALS INC | 200,000 | 2,892,000 | 1.06% | ||
| 48 | INCYTE CORP | 40,000 | 2,899,000 | 1.06% | Call | |
| 49 | BRISTOL MYERS SQUIBB CO | 50,000 | 3,194,000 | 1.17% | Call | |
| 50 | ALLSCRIPTS HEALTHCARE SOLUTN | 250,000 | 3,303,000 | 1.21% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001597549-16-000018, filed 2016.05.24).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
